SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 481 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $305 | -12.4% | 1,931 | -28.2% | 0.04% | -14.3% |
| Q1 2024 | $348 | -99.9% | 2,691 | -28.4% | 0.05% | -32.9% |
| Q3 2021 | $348,000 | +20.0% | 3,760 | +0.8% | 0.07% | +15.9% |
| Q2 2021 | $290,000 | +5.1% | 3,731 | +0.6% | 0.06% | -3.1% |
| Q1 2021 | $276,000 | -41.8% | 3,709 | +33.3% | 0.06% | -44.0% |
| Q4 2020 | $474,000 | +71.7% | 2,783 | +41.4% | 0.12% | +58.9% |
| Q3 2020 | $276,000 | +31.4% | 1,968 | +20.8% | 0.07% | +37.7% |
| Q4 2019 | $210,000 | – | 1,629 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |